Zum Seiteninhalt springen

The BIH Cohort Sequencing Program supports a broad range of sequencing technologies applied to patient cohorts and their respective preclinical models. Projects should have the potential to solve central questions of translational or clinical biomedicine within the BIH research foci (Single Cell Approaches for Personalized Medicine, Translational Vascular Biomedicine and Regenerative Therapies).

Preferably, samples have already been collected within a clinical trial to ensure availability. Prospective sampling is permitted if sampling and sequencing is completed within the year 2020. Funding will only be granted once the required sample number has been reached. Funding is limited to € 250,000 per project and all sequencing must be carried out by the BIH Core Unit Genomics.


All BIH/Charité/MDC scientists who dispose of independent research funding as well as participants of the BIH/Charité Clinician Scientist Program are eligible to apply for funding. Applicants are expected to have a contract with BIH, Charité or MDC that is secured for the duration of the proposed work.

Applications of mixed teams is encouraged (e.g., across institutions, disciplines, or joint teams of junior & senior groups or basic scientists and clinicians).

Scope and duration of funding

BIH Cohort Sequencing Grants are awarded for one year. Applications for follow-up funding are permitted and compete with all other applications submitted within a call for proposals. Only consumables are eligible for funding in order to promote cross-platform interactions.

In 2020, a budget of 1 Million € will be available for the program.

Selection procedure

The call for BIH Cohort Sequencing Grants is based on a two-stage selection procedure. In the first stage, applicants are invited to submit a pre-proposal. Applicants of the most promising pre-proposals will be invited to submit a full proposal in the second stage of the call. Applications need to be submitted via the online application portal (see link on the right-hand side).

Evaluation and selection of pre- and full proposals is based on a peer review process. In the first stage of the call, any Charité/MDC faculty member who is eligible to apply for this funding instrument can volunteer as reviewer provided that no own application has been submitted.

Evaluation criteria include:

  • fit with the objectives of the programs described above
  • translational potential of the project
  • scientific quality and originality
  • PI’s expertise in the field
  • adequate project plan and budget

Dates and deadlines

Deadline for the first stage:
24 February 2020 at 3 pm.

Invitation to submit full proposal:
13 March 2020

Deadline for the second stage:
6 April 2020 at 3 pm.


Dr. Christian Hirsch
+49 30 450 543 020

In case of technical problems with the portal, please send an e-mail to: portal@bihealth.de